Huertas Pedro 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 22, 2018
Insider Transaction Report
Form 4
Huertas Pedro
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-15+50,000→ 50,000 totalExercise: $6.65Exp: 2028-01-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period commencing on January 15, 2018 in sixteen equal quarterly installments.